This document is a stock report for Gentamicin 40mg/ml injection from December 29, 2023 to March 3, 2024. It shows the beginning stock of 2 units, various transactions that decreased the stock through use and increased it through procurement, and an ending stock of 91 units. Transactions included use of the item for patients identified by name and ID numbers, and procurement/transfer transactions identified by codes. The stock level fluctuated between issuances and receipts throughout the period.
This document is a stock report for Gentamicin 40mg/ml injection from December 29, 2023 to March 3, 2024. It shows the beginning stock of 2 units, various transactions that decreased the stock through use and increased it through procurement, and an ending stock of 91 units. Transactions included use of the item for patients identified by name and ID numbers, and procurement/transfer transactions identified by codes. The stock level fluctuated between issuances and receipts throughout the period.
This document is a stock report for Gentamicin 40mg/ml injection from December 29, 2023 to March 3, 2024. It shows the beginning stock of 2 units, various transactions that decreased the stock through use and increased it through procurement, and an ending stock of 91 units. Transactions included use of the item for patients identified by name and ID numbers, and procurement/transfer transactions identified by codes. The stock level fluctuated between issuances and receipts throughout the period.